This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Cincinnati Children's Hospital Medical Center. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Innovations in Neurodegenerative Disease Treatment by Ying Sun
Introduction
Ying Sun is a prominent inventor based in Mason, Ohio, known for his significant contributions to the field of neurodegenerative disease treatment. With a total of five patents to his name, he has made remarkable strides in developing innovative methods for addressing complex medical conditions.
Latest Patents
Ying Sun's latest patents focus on compositions and methods for the treatment of GCase-related disease states. These patents disclose innovative approaches for treating neurodegenerative diseases in individuals. The methods involve the administration of Integrin α4β1, Very Late Antigen-4 positive neural precursor cells (VLA4+NPC) that are transfected with a lentivirus overexpressing wild type GCase. This treatment targets various neurodegenerative disorders, including lipid storage diseases such as Gaucher disease, Parkinson's disease, and Dementia with Lewy bodies.
Career Highlights
Ying Sun is currently affiliated with the Children's Hospital Medical Center, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for debilitating neurodegenerative conditions.
Collaborations
Ying Sun collaborates with esteemed colleagues, including Benjamin Liou and Zhaolin Wang, to enhance the impact of his research. Their combined expertise fosters a collaborative environment that drives innovation in the medical field.
Conclusion
Ying Sun's contributions to the treatment of neurodegenerative diseases exemplify the power of innovation in medicine. His patents and collaborative efforts are paving the way for new therapeutic strategies that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
